eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | portal hypertension |
| Comorbidity | C0023895|hepatic disease |
| Sentences | 3 |
| PubMedID- 20500840 | Mean velocity (vmean), average portal blood flow volume (pbfv) and congestion index (ci) are important indicators in hepatic evaluation, mainly to detect alterations such as chronic hepatic diseases that lead to portal hypertension [1]. |
| PubMedID- 26029592 | Pulmonary syndromes in the setting of hepatic disease with portal hypertension include poph, hps and hepatic hydrothorax.1 poph is defined as pulmonary arterial hypertension with portal hypertension in the absence of other causes of pulmonary arterial hypertension.2 hps is a defect in arterial oxygenation as a result of pulmonary micro vascular dilatation in the setting of liver disease.8 there is no correlation between portal hypertension and the onset and severity of poph.3 in the setting of cirrhosis, the incidence of hps and poph is 4 to 29% and 0 to 7% respectively.1 the coexistence of poph and hps is rare but has been reported previously. |
| PubMedID- 20440575 | Plausible explanations include primary hepatic diseases with acute portal hypertension and splenic congestion; a left-sided intra-abdominal infection or malignancy (e.g., diverticulitis or colon cancer) spreading to the liver via the portal circulation; or a single malignant (e.g., lymphoma), infectious (e.g., endocarditis) or infiltrative (e.g., sarcoidosis) process simultaneously affecting the liver and spleen (or another left-sided abdominal organ). |
Page: 1